APPENDIX 2
Public hearing
Friday, 7 May 2010
Parliament House, Canberra
Committee Members in attendance
Senators Siewert (Chair)
Senator Claire
Moore (Deputy Chair)
Senator Concetta
Fierravanti-Wells
Senator Scott Ryan
Witnesses
Medicines Australia
Mr Will Delaat,
Chairman
Dr Brendan Shaw,
Chief Executive
Mr Andrew Bruce,
Executive Director, Health Policy and Research
Janssen-Cilag Australia
Mr Tim James,
Manager – Corporate and Government Affairs
Sanofi-aventis Australia
Mr Paul Lindsay,
Public Affairs Director
Dr Alex Condoleon,
Medical Director
AstraZeneca
Dr Simon Fisher,
Senior Director, Medical and Regulatory Affairs
Mr Kieran
Schneemann, Government Affairs Director
Pfizer Australia
Mr David Miles,
Senior Manager, Government Affairs
Dr Peter Stewart,
Primary Care Medical Head, Australia and New Zealand
Australian and New Zealand Bone and Mineral Society
Professor Markus
Seibel, Council Member
Chronic Illness Alliance via teleconference
Ms Jan Donovan
Arthritis Australia
Dr Mona Marabini,
President
Ms Ainslie Cahill,
Chief Executive Officer
Mental Health Council of Australia
Mr David Crosbie,
Chief Executive Officer
Ms Melanie
Cantwell, Deputy Chief Executive Officer
Carers Australia
Ms Sue Aiesi,
Policy, Communications and Research Manager
Ms Jessica Beswick,
Policy and Research Officer
MS Australia
Dr Elizabeth
McDonald, Medical Director
Pharmacy Guild of Australia
Ms Toni Riley,
National Councillor (Victoria)
Dr Michael
Tatchell, Director Health Economics
Mr Vincent
O'Sullivan, Manager Health Economics
Generic Medicines Industry Association
Ms Kate Lynch,
Chief Executive Officer
Consumers Health Forum of Australia
Ms Carol Bennett,
Executive Director
Ms Anna Wise,
Senior Policy Manager
Dr Stephen Oakley via teleconference
Dr Gabor Major
Dr Charles Inderjeeth via teleconference
Pharmaceutical Benefits Advisory Committee
Emeritus Professor
Lloyd Sansom, Chair
Department of Health and Ageing
Mr David Learmonth,
Deputy Secretary
Mr Andrew Stuart,
First Assistant Secretary, Pharmaceutical Benefits Division
Ms Felicity
McNeill, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical
Benefits Division
Dr John Primrose,
Medical Advisor, Pharmaceutical Benefits Division
Mr Kim Bessell,
Principal Pharmacy Advisor
Navigation: Previous Page | Contents